BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Friday, May 1, 2026
Home » Blogs » BioWorld MedTech Perspectives » Physician Payment Sunshine Act implementation right around the corner

BioWorld MedTech Perspectives
BioWorld MedTech Perspectives RSS FeedRSS

Medical technology

Physician Payment Sunshine Act implementation right around the corner

March 8, 2013
By Omar Ford
Are you ready

Are you ready? That's probably the most appropriate way to start off a blog entry concerning the soon to be implemented Physician Payment Sunshine Act. And the question isn't just for med-tech companies alone, it's for the physicians as well.

A recent survey conducted by MMIS, a company that develops secure communication solutions for firms, shows that physicians still aren't completely aware of the provision- which is set to go into effect in August (a little more than 4 months away. Yikes!). In a conversation with Medical Device Daily, Michaeline Daboul president/CEO MMIS said that survey results of the more than 1,000 physicians questioned show that more than half admitted they didn't know that the law required medical device companies and pharmaceutical companies to report on expenditures annually, without physician review of the data to correct any inconsistencies or errors prior to submission to the government.

Now there are probably tons of reasons why these physicians were unprepared for certain aspects of this law. Perhaps firms were hedging their bets that the Presidential election would go another way and that many provisions of the Affordable Care Act would be thrown out. Well that didn't happen and now med-tech companies and physicians have to deal with the law - or face hefty fines and damaged relationships if they aren't in compliance.

But that's where companies like MMIS come in. The company has designed a network that will allow physicians to become more familiar with the process and also view and possibly dispute payment entries prior to these said entries being made public.

It's an interesting network and MMIS has been talking to MDD about this for the last two years.

Obviously this company is ready, the question is are the med-tech firms and physicians out there ready?

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for April 30, 2026.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for April 28, 2026
  • Chinabio 2026 partnering

    Chinese biotechs gain leverage as partners in dealmaking

    BioWorld
    China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
  • AI generated image for researcher developing antisense oligonucleotides

    Bio Korea 2026 kicks off with spotlight on oligonucleotides

    BioWorld
    Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
  • Roche identifies new TREM2 agonists

    BioWorld Science
    F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing